ONWARD ARC-EX® System Named One of TIME's Best Inventions of 2024
31 oct. 2024 01h30 HE
|
ONWARD Medical NV
ONWARD ARC-EX® System Named One of TIME's Best
Inventions of 2024
ONWARD® Medical Publishes Closing of Bookbuild Offering
28 oct. 2024 12h45 HE
|
ONWARD Medical NV
ONWARD® Medical Publishes Closing of Bookbuild Offering
ONWARD® Medical Publishes Prospectus for Listing of New Shares
24 oct. 2024 11h45 HE
|
ONWARD Medical NV
ONWARD® Medical Publishes Prospectus for Listing of New
Shares
ONWARD® Medical Successfully Raises EUR 50 Million in an Upsized Capital Increase with Cornerstone Investment from Ottobock SE & Co. KGaA
24 oct. 2024 01h30 HE
|
ONWARD Medical NV
ONWARD® Medical Successfully Raises EUR 50 Million in an Upsized Capital Increase with Cornerstone Investment from Ottobock SE & Co. KGaA
ONWARD® Medical lève avec succès 50 millions d’euros dans le cadre d’une levée de fonds majorée avec le soutien d’Ottobock SE & Co. KGaA
24 oct. 2024 01h30 HE
|
ONWARD Medical NV
Ottobock, un leader mondial dans le domaine des prothèses, des orthèses et des exosquelettes, acquiert environ 10% du capital d’ONWARD Medical N.V. concrétisant un partenariat stratégique La...
ONWARD® Medical lance une augmentation de capital d’un montant d’environ 40 millions d’euros dont 22,5 millions d’engagement ferme de la part d’Ottobock SE & Co. KGaA
22 oct. 2024 14h21 HE
|
ONWARD Medical NV
NE PAS DISTRIBUER OU DIFFUSER, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS, AU CANADA, EN AUSTRALIE OU AU JAPON OU DANS TOUTE AUTRE JURIDICTION DANS LAQUELLE LA DISTRIBUTION OU LA DIFFUSION SERAIT...
ONWARD® Medical Launches Capital Increase for Indicative Amount of c. EUR 40 Million including EUR 22.5 Million Cornerstone Investment from Ottobock SE & Co. KGaA
22 oct. 2024 11h45 HE
|
ONWARD Medical NV
ONWARD® Medical Launches Capital Increase for Indicative Amount of c. EUR 40M including EUR 22.5M Cornerstone Investment from Ottobock SE & Co. KGaA
ONWARD® Medical Announces Changes to Board of Directors, Including Addition of Medtech Leader Rob ten Hoedt as Incoming Chairman
21 oct. 2024 01h30 HE
|
ONWARD Medical NV
ONWARD® Medical Announces Changes to Board of
Directors, Including Addition of Medtech Leader Rob ten
Hoedt as Incoming Chairman
ONWARD® Medical signe un accord avec le CEA pour obtenir les droits exclusifs de la technologie d’interface cerveau machine (BCI) WIMAGINE® de Clinatec
15 oct. 2024 01h30 HE
|
ONWARD Medical NV
CE COMMUNIQUÉ DE PRESSE CONTIENT DES INFORMATIONS PRIVÉES AU SENS DE L'ARTICLE (7)(1) DU RÈGLEMENT EUROPÉEN SUR LES ABUS DE MARCHÉ (596/2014) L'entreprise obtient les droits exclusifs pour intégrer...
ONWARD® Medical Signs Agreement with CEA for Exclusive Rights to Clinatec’s WIMAGINE® Brain-Computer Interface (BCI) Technology
15 oct. 2024 01h30 HE
|
ONWARD Medical NV
ONWARD® Medical Signs Agreement with CEA for Exclusive Rights to Clinatec’s WIMAGINE® Brain-Computer Interface (BCI) Technology